Ensysce Biosciences, Inc. (ENSC) Total liabilities 2020–2025
Ensysce Biosciences, Inc. (ENSC) total liabilities at each fiscal year-end, per SEC filings.
$4.6MFY2025 · since FY2020: $7.0M → $4.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.6M | +106.0% |
| FY2024 | $2.2M | -34.0% |
| FY2023 | $3.4M | -66.1% |
| FY2022 | $9.9M | -59.7% |
| FY2021 | $24.6M | +250.6% |
| FY2020 | $7.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice